Pharmaceuticals
-
Pharma Stock Plummets, But Major Catalyst Looms
The stock market showed resilience, driven by gains in semiconductors and AI, with TSMC leading the charge. Financials also performed well, with Goldman Sachs and BlackRock reporting strong quarters. However, an “overbought” market prompted the CNBC Investing Club to raise cash. Eli Lilly dipped due to FDA review delays for drug candidates, while Costco saw renewed analyst enthusiasm. Upcoming economic data includes industrial production and housing index figures.
